Cambridge Investment Research Advisors, Inc. Pacific Biosciences Of California, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,934 shares of PACB stock, worth $15,991. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,934
Previous 102,801
88.39%
Holding current value
$15,991
Previous $1.01 Million
95.54%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PACB
# of Institutions
293Shares Held
253MCall Options Held
1.42MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.3MShares$44.6 Million0.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$31.3 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$23.6 Million9.04% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.12.8MShares$17.2 Million0.03% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $301M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...